Abstract

Engagement of the T cell receptor molecules with MHC-antigen complexes presented by B cells ascertains antigen specificity in T cell-dependent help. Ligation of MHC molecules on the surface of B cells, however, has not only been implicated in antigen-specific T-B cell interaction, but has also been linked to the induction of B cell apoptosis. To examine the role of T helper cells in either induction of immunoglobulin synthesis or B cell apoptotic death, we have facilitated T cell receptor-MHC interaction through a bacterial superantigen. CD4+ T cell clones could be categorized into two clearly distinct subsets based upon their ability to promote B cell help in the presence of superantigen. One subset of T cell clones supported immunoglobulin synthesis, and thus functioned as effective helper cells. B cells interacting with the second subset of T cells did not differentiate into antibody-secreting cells, but underwent apoptosis. Both types of helper cells were able to provide contact help after anti-CD3 stimulation. Induction of apoptosis was a dominant phenomenon; the addition of the superantigen suppressed immunoglobulin production in B cells activated by anti-CD3-stimulated helper T cells, indicating that the T cells delivered an apoptotic signal to the B cell. T cell clones providing effective MHC restrictive B cell help could be distinguished from T cells facilitating B cell apoptosis based on their lymphokine secretion profile. Induction of B cell apoptosis was a feature of T cells with a TH0 lymphokine pattern. Promotion of MHC-restricted B cell help was associated with a TH2 lymphokine profile. TH1-derived cytokines alone could not substitute for apoptosis-inducing T cells.

Authors

Guidelines:
The Editorial Board will only consider letters that we deem relevant and of interest to our readers. We
will not post data that have not been subjected to peer review, nor will we post letters that are
essentially a reiteration of another letter. All accepted letters will be posted on our website within
one week of acceptance. We reserve the right to edit any letter for length, content, and clarity.
Authors of all accepted letters will be asked to preview any changes. Authors will be notified by e-mail
if their letters were not accepted. As this is a final decision, no appeals will be considered.

Specific requirements: All letters must be 400 words or fewer. You may enter the letter as plain
text or HTML. The author's name and e-mail address are required, and will be posted with the letter. All
possible conflicts of interest must be noted, even if they are not posted. If you wish to include a
figure (keep in mind that non-peer-reviewed data will not be posted), please contact the editors
directly at editors@the-jci.org.

First nameThis field is required

Last nameThis field is required

PositionThis field is required

InstitutionThis field is required

Email addressThis field is required

Other authors (Enter the list of colleagues in the following form: Stephanie Fulton, Thomas L. Wilding, and Frances Groen.)